首页> 外文期刊>Traditional medicine research. >Analysis of the action mechanism of Fang Ji Huang Qi decoction in treating rheumatoid arthritis by network pharmacology
【24h】

Analysis of the action mechanism of Fang Ji Huang Qi decoction in treating rheumatoid arthritis by network pharmacology

机译:方药黄芪汤治疗类风湿关节炎的网络药理作用分析

获取原文
           

摘要

Highlights The present study preliminarily verified the basic pharmacological action and its mechanism of Fang Ji Huang Qi decoction in the treatment of rheumatoid arthritis. Editor’s Summary The method of network pharmacology not only preliminarily demenstrated the use of Fang Ji Huang Qi decoction in the treatment of rheumatoid arthritis, but also suggested its potential application in the treatment of cancer. Objective To explore the pharmacological action mechanism of Fang Ji Huang Qi decoction (FHD) in the treatment of rheumatoid arthritis (RA) by network pharmacology. Methods The chemical compositions and functional targets of the TCM were retrieved using the systematic pharmacological analysis platform TCMSP, and the gene name of each target protein was obtained from the UniProtKB network platform. The targets of RA were queried through the CTD database. The protein-protein interaction network was constructed in the STRING database, and the network visualization analysis was performed in Cytoscape. The Gene Ontology and Kyoto Gene and Genomic Encyclopedia pathways enrichment analyses of key target proteins were performed using the DAVID data platform. Results A total of 472 drug active ingredients were screened from the TCMSP database. Seventy-five disease targets from the CTD database were screened. The compound-target network map contained further screened out 98 components and corresponding 75 targets. The key compounds included quercetin and kaempferol. The key targets were prostaglandin G/H synthase 2 and nitric oxide synthase 2. The protein-protein interaction network consisted of 75 proteins, of which 37 were key proteins, including tumor protein 53, JUN and interleukin-6. There were 260 Gene Ontology entries, of which 246 were biological processes. Fifty-five Kyoto Gene and Genomic Encyclopedia pathways were enriched, mainly the cancer pathway, NOD-like receptor signaling pathway, and Toll-like receptor signaling pathway, which are involved in the action mechanism of FHD. Conclusion The results of this study preliminarily verified the basic pharmacological action mechanism of FHD in the treatment of RA, laying a foundation for elucidating its mechanism of action.
机译:要点本研究初步验证了方济黄芪汤治疗类风湿关节炎的基本药理作用及其作用机理。编者的总结网络药理学方法不仅初步证明了方济黄芪汤在类风湿关节炎的治疗中的应用,而且还暗示了其在癌症治疗中的潜在应用。目的探讨方济黄芪汤(FHD)通过网络药理学治疗类风湿关节炎(RA)的药理作用机理。方法利用系统的药理分析平台TCMSP检索中药的化学成分和功能靶标,并从UniProtKB网络平台获取各靶蛋白的基因名称。通过CTD数据库查询RA的目标。在STRING数据库中构建了蛋白质-蛋白质相互作用网络,并在Cytoscape中进行了网络可视化分析。使用DAVID数据平台对关键目标蛋白进行了基因本体论和Kyoto基因及基因组百科全书路径富集分析。结果从TCMSP数据库中共筛选了472种药物活性成分。从CTD数据库中筛选了75种疾病目标。复合目标网络图包含进一步筛选出的98个组件和相应的75个目标。关键化合物包括槲皮素和山奈酚。关键靶点是前列腺素G / H合酶2和一氧化氮合酶2。蛋白-蛋白相互作用网络由75种蛋白组成,其中37种是关键蛋白,包括肿瘤蛋白53,JUN和白介素6。基因本体论条目有260个,其中246个是生物学过程。丰富了《京都议定书》第五十五条基因和基因组百科全书的途径,主要是癌症途径,NOD样受体信号通路和Toll样受体信号通路,它们参与了FHD的作用机制。结论本研究结果初步验证了FHD治疗RA的基本药理作用机理,为阐明其作用机理奠定了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号